Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
NCT05649280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-12-14
Summary
The objective of this study is to evaluate the incidence of ACS within the DREPADOM system and compare it to expected incidences of ACS (historic cohorts of PRESEV1 and PRESEV2)
Conditions
Sponsors & Collaborators
-
Soutien aux Actions contre les Maladies du Globule Rouge
lead OTHER
Principal Investigators
-
Pablo BARTOLUCCI, PROFESSOR · Soutien aux Actions contre les Maladies du Globule Rouge
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2022-02-01
- Completion
- 2022-06-01
Countries
- France
Study Locations
More Related Trials
-
Prognostic Factors of Acute Splenic Sequestration
NCT01207037 ·Status: COMPLETED ·Phase: NA
-
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
NCT01178099 ·Status: COMPLETED ·Phase: PHASE1
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
NCT03572036 ·Status: COMPLETED
-
Transfusion Exchanges and Cognition in Sickle Cell Disease
NCT07168447 ·Status: NOT_YET_RECRUITING
-
Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France
NCT05153044 ·Status: UNKNOWN ·Phase: NA
-
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
NCT05211037 ·Status: COMPLETED ·Phase: NA
-
Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department
NCT02386657 ·Status: COMPLETED
-
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
NCT03132324 ·Status: TERMINATED ·Phase: PHASE1
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING
-
"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease
NCT05407740 ·Status: COMPLETED
-
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
NCT03263364 ·Status: UNKNOWN
-
Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of Adults and Parents of Children Living with Sickle- Cell Disease in France
NCT04413539 ·Status: COMPLETED
-
Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound
NCT02829580 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Ultrasound in the Diagnosis of Acute Thoracic Syndrome in Vaso-occlusive Sickle Cell Crisis
NCT03971136 ·Status: UNKNOWN ·Phase: NA
-
A GBT021601 ADME Microtracer Study in Healthy Volunteers
NCT05718687 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease
NCT05725902 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.
NCT03368261 ·Status: COMPLETED ·Phase: NA
-
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
NCT03805581 ·Status: COMPLETED ·Phase: PHASE2
-
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
NCT00495638 ·Status: COMPLETED
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED
-
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
NCT05053932 ·Status: UNKNOWN
-
Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease
NCT06769139 ·Status: NOT_YET_RECRUITING
-
Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients
NCT07000747 ·Status: RECRUITING
-
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
NCT03240731 ·Status: COMPLETED ·Phase: PHASE2